NCT04822779

Brief Summary

Rotator cuff tendinitis (RCT) has a prevalence between 2.7 and 22%, and predominantly affects middle-aged women. The pathophysiology has not been fully elucidated to date. RCT is characterized by hydroxyapatite crystal deposition in the rotator cuff tendons. Approximately half of the patients with RCT have pain with acute or chronic shoulder mobility limitation. In some patients, RCT shows a tendency for spontaneous and rapid regression. Diagnostic ultrasound (D-US) is a non-invasive, non-ionizing, and relatively inexpensive diagnostic imaging method that is safe and reliable in assessing rotator cuff pathology. It is very sensitive in the identification of calcifications that are shown in grayscale (B-mode) as hyperechoic structures with or without acoustic shadow. Based on ultrasound findings, Chiou HJ et al. have classified calcifications into 4 types: type I are arcuate, type II are fragmented or punctiform, type III are nodular, and type IV are cystic. Spontaneous resorption may occur with type III and IV calcifications. A positive Doppler signal (PD) surrounding the calcification is highly correlated with pain intensity. According to the European Union of Medical Specialists-Physical and Rehabilitation Medicine (UEMS-PRM) guidelines, the basis of RCT therapy is individual medical gymnastics (IMG). It includes exercises aimed to restore full shoulder mobility, and improve rotator cuff and scapular stabilizer muscles strength. Other passive procedures are elective in the choice of treatment. Ultrasound therapy is often used in the treatment of musculoskeletal shoulder pathology due to its thermal and non-thermal effects. It is considered that tissue heating stimulates healing (vasodilation, acceleration of the metabolism, and improvement of the viscoelastic properties of the connective tissue). The frequency of ultrasound therapy is selected depending on the desired depth of action (3 MHz for surface structures up to 2.5 cm depth, and 1 MHz for deeper structures, up to 5 cm depth). Pulse mode is commonly used in acute, while continuous in chronic conditions. To date, only a few studies have evaluated the reduction in calcification size after ultrasound therapy. Although ultrasound therapy is routinely used in the treatment of painful shoulder, reviewing the results of research published so far, we can say that current knowledge about the effectiveness of ultrasound therapy in RCT is inconsistent (only several studies with a small number of subjects, different parameters of applied ultrasound therapy in terms of penetration depth, applied energy and duration of treatment). This indicates the need for further research.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 30, 2021

Completed
2 days until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

April 1, 2021

Status Verified

March 1, 2021

Enrollment Period

1 year

First QC Date

March 26, 2021

Last Update Submit

March 29, 2021

Conditions

Keywords

ultrasound therapyrehabilitationkinesiotherapydiagnostic ultrasound

Outcome Measures

Primary Outcomes (1)

  • The change in calcification size measured by D-ultrasound before and after the intervention.

    The researcher will perform an ultrasound examination of the shoulder immediately before and immediately after the therapeutic intervention. The size of the calcification will be measured according to the standard size measurement protocol, and another examiner will make an independent measurement. The final measure will take the average value of the two.

    4 weeks

Secondary Outcomes (4)

  • To compare the effectiveness of therapeutic ultrasound in combination with individual medical gymnastics with the effectiveness of individual medical gymnastics in reducing pain.

    4 weeks

  • To compare the effectiveness of therapeutic ultrasound in combination with individual medical gymnastics with the effectiveness of individual medical gymnastics on increasing shoulder mobility.

    4 weeks

  • To compare the effectiveness of therapeutic ultrasound in combination with individual medical gymnastics with the effectiveness of individual medical gymnastics on improving the functional status of the shoulder.

    4 weeks

  • To compare the effectiveness of therapeutic ultrasound in combination with individual medical gymnastics with the effectiveness of individual medical gymnastics on the overall satisfaction with the outcome of rehabilitation.

    4 weeks

Study Arms (2)

Active Group

ACTIVE COMPARATOR

This group will receive ultrasound therapy. Respondents will conduct individual medical-gymnastics: unloading pendular exercises if strength exercises cannot be started immediately, shoulder range exercises, and rotator cuff and scapula stabilizer exercises for 30 minutes per treatment.

Device: Sonopuls 490u, Enraf-Nonius, Rotterdam, Kingdom of the Netherlands

Control Group

SHAM COMPARATOR

This group will receive sham ultrasound therapy. Respondents will conduct the same individual medical-gymnastics, as in the active group: unloading pendular exercises if strength exercises cannot be started immediately, shoulder range exercises, and rotator cuff and scapula stabilizer exercises for 30 minutes per treatment.

Other: Placebo

Interventions

Ultrasound therapy will be applied in continuous output, 1 MHz frequency, the intensity of 1.5 W / cm2, and duration 10 min per treatment, on the front of the shoulder, on the surface of 2 ultrasound heads (10 cm2). The position of the arm will be in adduction and internal rotation in RCT of the supraspinatus, adduction and external rotation of the arm in RCT of the subscapularis, and the position of the arm over the opposite shoulder in RCT of the infraspinatus.

Active Group
PlaceboOTHER

Sham ultrasound therapy will be applied using a frequency of 0 Hz, intensity 0 W / cm2, 10 min per treatment. The position of the arm will be in adduction and internal rotation in RCT of the supraspinatus, adduction and external rotation of the arm in RCT of the subscapularis, and the position of the arm over the opposite shoulder in RCT of the infraspinatus.

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • symptomatic RCT (VAS pain ≥ 4 + limited shoulder mobility) with D-ultrasound calcification size ≥ 5 mm
  • calcification type I and II according to Chiou HJ et al.
  • disease duration ≥ 2 months

You may not qualify if:

  • asymptomatic RCT or RCT with mild symptoms (VAS pain ≤ 3 + normal shoulder mobility)
  • calcification size \< 5 mm, type III and IV calcification according to Chiou HJ et al.
  • duration symptoms less than 2 months
  • rotator cuff tendon rupture
  • adhesive capsulitis
  • application of corticosteroids in the examined shoulder in the previous 3 months
  • glucocorticoid therapy
  • physical shoulder therapy in the previous 6 months
  • shock wave therapy in the previous 12 months
  • prior percutaneous calcification irrigation
  • current cervical or cervicobrachial pain syndrome
  • inflammatory rheumatic disease
  • scapular dyskinesia with positive assisted and repository scapular test
  • subacromial/subdeltoid bursitis
  • recent trauma or malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Department for Rheumatology and Rehabilitation, Clinical Hospital Centre Zagre

Zagreb, City of Zagreb, 10000, Croatia

RECRUITING

Related Publications (6)

  • Chiou HJ, Chou YH, Wu JJ, Hsu CC, Huang DY, Chang CY. Evaluation of calcific tendonitis of the rotator cuff: role of color Doppler ultrasonography. J Ultrasound Med. 2002 Mar;21(3):289-95; quiz 296-7. doi: 10.7863/jum.2002.21.3.289.

    PMID: 11883540BACKGROUND
  • Varela E, Valero R, Kucukdeveci AA, Oral A, Ilieva E, Berteanu M, Christodoulou N; UEMS-PRM Section Professional Practice Committee. Shoulder pain management. The role of physical and rehabilitation medicine physicians. The European perspective based on the best evidence. A paper by the UEMS-PRM Section Professional Practice Committee. Eur J Phys Rehabil Med. 2013 Oct;49(5):743-51.

    PMID: 24145232BACKGROUND
  • Alexander LD, Gilman DR, Brown DR, Brown JL, Houghton PE. Exposure to low amounts of ultrasound energy does not improve soft tissue shoulder pathology: a systematic review. Phys Ther. 2010 Jan;90(1):14-25. doi: 10.2522/ptj.20080272. Epub 2009 Nov 12.

    PMID: 19910457BACKGROUND
  • Ebenbichler GR, Erdogmus CB, Resch KL, Funovics MA, Kainberger F, Barisani G, Aringer M, Nicolakis P, Wiesinger GF, Baghestanian M, Preisinger E, Fialka-Moser V. Ultrasound therapy for calcific tendinitis of the shoulder. N Engl J Med. 1999 May 20;340(20):1533-8. doi: 10.1056/NEJM199905203402002.

    PMID: 10332014BACKGROUND
  • Williams JW Jr, Holleman DR Jr, Simel DL. Measuring shoulder function with the Shoulder Pain and Disability Index. J Rheumatol. 1995 Apr;22(4):727-32.

    PMID: 7791172BACKGROUND
  • Philadelphia Panel. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for shoulder pain. Phys Ther. 2001 Oct;81(10):1719-30.

    PMID: 11589645BACKGROUND

MeSH Terms

Conditions

Rotator Cuff InjuriesShoulder PainMusculoskeletal Diseases

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon InjuriesArthralgiaJoint DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Stjepan Čota, MD

CONTACT

Nadica Laktašić Žerjavić, Assist. Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Randomization of patients will be performed before the intervention in the R software package and the results of the randomization will be known only to the therapist who will be involved in the treatment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The research will be a double-blind randomized control prospective study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Stjepan Čota, MD

Study Record Dates

First Submitted

March 26, 2021

First Posted

March 30, 2021

Study Start

April 1, 2021

Primary Completion

April 1, 2022

Study Completion

January 1, 2023

Last Updated

April 1, 2021

Record last verified: 2021-03

Locations